Neuronetics (STIM) Income from Non-Controlling Interests (2025 - 2026)
Neuronetics (STIM) reported Income from Non-Controlling Interests of $10000.0 for Q1 2026, up 171.43% year-over-year from $3684.2 in Q1 2025, and up 120.83% quarter-over-quarter from -$48000.0 in Q4 2025.
Neuronetics (STIM) Income from Non-Controlling Interests (2025 - 2026) Analysis & Trends
Neuronetics (STIM) has 2 years of Income from Non-Controlling Interests data on file, last reported at $10000.0 in Q1 2026.
- Income from Non-Controlling Interests for Q1 2026 came in at $10000.0, up 171.43% year-over-year; the trailing twelve-month figure through Mar 2026 was -$113000.0 (changed N/A YoY), and the FY2025 annual result was -$137000.0, down 621.05% from the prior year.
- Income from Non-Controlling Interests rose to $10000.0 in Q1 2026 per STIM's latest filing, from -$48000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $281000.0 in Q2 2025 and troughed at -$356000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 100,000.00 |
| 10 | Neuronetics | 2.40 Mn | -7.28 Mn | 16.15 Mn | 10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | -48,000.00 |
| Sep 30, 2025 | -356,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | -14,000.00 |